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The  inoculation  of  Moloney  sarcoma  virus  (MoSV)l-murine  leukemia  virus 
(MoLV)  complex  into  immunocompetent  mice  results  in  the  development  of  a 
sarcoma at the site of injection that spontaneously regresses (1).  Temporally related 
to the regression of these tumors is the appearance of cytolytic T  lymphocytes (CTL) 
specific for MoLV-associated cell surface antigens.  MoLV-specific CTL activity has 
been detected in the spleens and tumors of mice at the time of the regression of these 
sarcomas  (1-4)  and  has  been  generated  in  vitro  by stimulating  spleen  cells  from 
normal mice or from mice that have rejected their sarcomas (regressors) with irradiated 
MoLV-induced  lymphomas  in  mixed  leukocyte-tumor  cell  cultures  (MLTC)  (5). 
Studies that examined the specificity of CTL activity have demonstrated H-2 restric- 
tion  of recognition of MoLV-associated cell surface antigens  (6).  More specifically, 
lysis of H-2  b MoLV-derived target cells requires  identity at the  H-2D  b locus of the 
CTL population and target cells, whereas lysis of H-2  a MoLV-derived targets requires 
identity at  H-2K  a  (7).  Further characterization  of these effector cells has suggested 
that they express the Lyt-1-2  + phenotype (8).  However, the interpretation of studies 
that  examined  the  specificity and  nature  of MoLV-specific CTL has  been  limited 
because heterogeneous cell populations that contained the relevant CTL in unknown 
concentrations were used. 
The application of limiting-dilution analysis toward the study of the clonal progeny 
of CTL-precursors  (CTL-P)  has  been  reported  by  several  groups  (9-12)  and  has 
recently been applied by this laboratory to the study of homogeneous MoLV-specific 
CTL populations  (13).  In initial experiments that employed a  MLTC microcuhure 
system  (micro-MLTC), conditions  required  for the detection  of CTL-P progeny at 
the  clonal  level  were  defined,  and  preliminary  studies  of CTL-P  frequency  and 
specificity were carried  out  (13).  Interestingly,  these  specificity studies  suggested  a 
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degree of heterogeneity of the clones generated with C57BL/6  regressor spleen cells. 
However, further analysis of such clones was limited by the relatively small number 
of cells available at any one time. 
In  the  studies  reported  here,  advantage  was  taken  of  the  high  frequency  of 
operational  CTL-P  generated  after  in  vitro  stimulation  of  regressor  spleen  cell 
populations with MoLV-infected spleen cells. Large numbers of homogeneous CTL 
were obtained from such populations by first selecting and subsequently expanding 
clones obtained under limiting-dilution conditions. These expanded clones were then 
analyzed in detail for specificity, phenotypic stability, and Lyt phenotype. 
Materials  and  Methods 
Mice.  Adult C57BL/6  (H-2  b)  mice used  in  these experiments were  bred  in  the  animal 
facilities at  the  Swiss  Institute for  Experimental Cancer  Research,  Epalinges,  Switzerland. 
Original breeding pairs were obtained from The Jackson Laboratory, Bar Harbor, Maine. 
Tumor Cell Lines.  MBL-2  (H-2b),  an  MoLV-induced  lymphoma,  and  RBL-5  (H-2b),  a 
Rauscher leukemia virus-induced lym~,homa, were maintained by serial passage of the ascitic 
forms in C57BL/6 mice. LSTRA (H-2), an MoLV-indueed lymphoma, and P-815 (H-2  d) and 
EL-4  (H-2b), chemically induced tumors, were  maintained  in  vitro in  Dulbecco's modified 
Eagle's medium supplemented with 10% fetal bovine serum (FBS). 
Generatwn of CTL in Mass Culture.  Regressor spleen cells were obtained from 3- to 4-wk-old 
C57BL/6 mice 14 d  after an intramuscular injection of 0.1  ml of MoSV-MoLV complex (5). 
Mass cultures were prepared with  30  ×  106  regressor (responder)  spleen cells and  6  ×  106 
MoLV-infected syngeneic (stimulator) spleen cells (mice were injected with a MoLV prepara- 
tion within 24 h of birth, and spleen cells from these mice were used at 4 wk of age)  2 in 20 ml 
of Dulbecco's modified Eagle's medium supplemented with additional amino acids (14),  5 × 
10  -5 M  2-mercaptoethanol, and  2%  FBS  (culture medium),  in upright  50-ml tissue culture 
flasks (Nunc, Roskilde, Denmark). After 7 d of culture at 37°C in a humidified atmosphere of 
5% CO2 in air, an aliquot of cells was tested for cytolytic activity; the remaining cells, from 
several  flasks, were  pooled  and  frozen  at  -80°C  in  culture  medium  that  contained  10% 
dimethyl sulfoxide (DMSO) and 10% FBS. 
Micro-MLTC.  Micro-MLTC were  prepared  in  culture medium  supplemented with  10% 
FBS and 25%  (vol:vol) secondary mixed leukocyte culture (MLC) supernate  (SN)  (2 °  MLC 
SN)  as a  source of T  cell growth  factor  (15).  Each  culture contained  limiting numbers  of 
responder cells, 1 ×  106 irradiated (2,000  rad) syngeneic spleen cells, and 3 X  104 irradiated 
(5,000  rad)  syngeneic  (stimulators)  MBL-2  tumor  cells in  a  final  vol  of 0.2  ml  in  round- 
bottomed microwelis (Greiner, Nfirtingen, Federal Republic of Germany)  (13).  After 7 d  of 
culture, cell growth was assessed microscopically  and aliquots were removed to measure cytolytic 
activity. 
Maintenance of CTL Clones.  CTL clones derived from microcultures were transferred to and 
maintained in 1-ml cultures that contained 5 X 10  e irradiated (2,000 rad) syngeneic spleen cells 
and 3 ×  l0  s irradiated (5,000  rad) MBL-2 tumor cells in culture medium supplemented with 
10% FBS and 25% MLC SN in 16-mm muhiwell plates (Costar, Data Packaging, Cambridge, 
Mass.). After initial expansion, clones were passaged every 3-5 d by transferring 5 ×  104 cells 
to fresh cultures. Aliquots of cells were periodically frozen at -80°C in culture medium that 
contained 10% DMSO and  10% FBS. 
Assay for Cytolytic Activity.  Cytolytie activity of effeetor cells was determined using a  51Cr- 
release assay (16). Briefly, aliquots of effector cells were mixed with either 2,000  or 5,000  51Cr- 
labeled tumor cells (as indicated) in a  final vol of 200/zl in round-bottomed mieroplates and 
incubated for 3.5 h at 37°C. The assay plates were then centrifuged, and 100/zl of the SN fluid 
was  removed  and  the amount  of released 5~Cr determined  in  a  well-type gamma  counter. 
Controls included maximal release of 5tCr as the result of freezing and thawing targets, and 
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spontaneous release of SXCr from labeled targets in the absence of effector cells. Percent-specific 
release or lyric units (LU) were calculated as previously described (16);  1 LU was equivalent to 
the number of lymphocytes required to produce 50% specific 5~Cr release. 
Frequency of CTL-P.  The method used for the calculation of CTL-P is described in detail 
elsewhere,  a Briefly, 24 replicate microcultures prepared with varying numbers of responding 
cells were assessed for cytolytic activity. Positive cultures were defined as those in which the 
S~Cr release values exceeded by 3SD the spontaneous release values. Minimal estimates of CTL- 
P frequencies were calculated by analysis of the Poisson distribution relationship between the 
number  of responding  cells/mieroculture  and  the  percentage  of nonresponding  cultures. 
Experimental values were fit to the zero-order-term Poisson equation by the maximum  log 
likelihood method,  a 
Alloantisera and Monoclonal Antibodies.  Hyperimmune C57BL/6 anti-DBA/2 (anti-H-2  d) and 
DBA/2 anti-C67BL/6  (anti-H-2  b) ailoantisera were produced by intraperitoneal injection of 
recipient mice with 5 ×  107 allogeneic spleen cells three to six times at 3-wk intervals. 7 d after 
the last injection, mice were exsanguinated and serum collected, filtered, and heat-inactivated. 
Ascitic fluids that contained monoclonal antibodies produced by hybridomas B22-249.R1 
and  H141-30,  specific for H-2D  b, were obtained from G.  H~mmerling,  Deutsches Krebsfor- 
schungszentrum,  Heidelberg,  Federal  Republic  of Germany.  Their  reactivity patterns  are 
described in detail elsewhere (17). Serum that contained monoclonal antibody produced by the 
hybridoma B8-24-1,  specific for  H-2K  b,  was  obtained  from  G.  K6hler,  Basel  Institute  for 
Immunology, Basel, Switzerland. 
Concentrated culture SN that contained rat monoclonal antibodies directed against nonpol- 
ymorphic determinants of either Lyt-1  (53-7.3)  or Lyt-2 (53-6.7)  molecules were used in the 
analysis of the Lyt phenotype of MoLV-specific CTL clones. The reactivity pattern of these 
antibodies has previously been described (18). 
Fluorescein-labeled rabbit anti-rat IgG was purchased from Nordic Immunological Labo- 
ratories (Tilburg, The Netherlands). 
Fluorescent Staining and Flow Cytometric Analysis.  Indirect immunofluorescence was performed 
on Ficoll-Hypaque-purified lymphoid cell samples of 0.3-1  X  l0  s cells. Cells in a  0.1-ml vol 
were incubated with appropriate concentrations of rat monoclonal antibody directed against 
Lyt-1 or Lyt-2 at 4°C for 30 rain. After washing, cell pellets were resuspended for 30 min at 
4°C in 0.1 ml of medium that contained fluoresceinated rabbit anti-rat IgG. Control samples 
were incubated in the fluorescein conjugate only. Samples were then finally centrifuged over a 
layer of FBS and analyzed on a  flow eytometer (FACS II; B.  D.  FACS Systems, Mountain 
View, Calif.). 
Flow cytometric analysis was performed as described in detail elsewhere.  4 Briefly, the FACS 
II,  modified  to  allow  three  parameter  analysis, was  routinely gated  for  viable cells by  a 
combination of narrow-angle forward light scatter and perpendicular light scatter. Fluorescence 
was the third parameter measured. Approximately 30,000 gated events were accumulated for 
each determination. 
Results 
Production  of MoLV-Specific  CTL  Clones.  Preliminary  studies  had  shown  that  the 
frequency of MoLV-specific CTL-P increased dramatically (from -  1/60o up to 1/2) after 
in  vitro  stimulation  of  C57BL/6  regressor  spleen  cells  with  syngeneic  irradiated 
MoLV-induced  MBL-2  lymphoma cells (or with  MoLV-infected spleen cells). This 
suggested the use of in vitro stimulated cells as the starting population in attempts to 
derive MoLV-specific CTL clones, rather than  the regressor spleen cells used in the 
previous studies (13). Limiting numbers of cells (three cells/well) obtained at the peak 
z Taswell, C. Limiting dilution assays for the determination  of immunocompetent  cell frequencies. I. 
Data analysis. Manuscript submitted for publication. 
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increase in expression of the T cell surface markers Thy-1, Lyt-1 and Lyt-2 in congenitally athymic (nu/ 
nu) mice: analysis by flow microfluorometry. Manuscript  submitted for publication. A.  WEISS,  K.  BRUNNER,  H.  MACDONALD,  AND J.-C.  CEROTTINI  1213 
of the CTL response (day 7) of C57BL/6 regressor spleen cells stimulated with MoLV- 
infected C57BL/6 spleen cells were cultured in micro-MLTC with  1 ×  106 syngeneic 
irradiated spleen (accessory) cells and 3 ×  104 irradiated MBL-2 tumor (stimulator) 
cells, and 2 ° MLC SN as a source oft  cell growth factor. After 7 d, each culture was 
assessed microscopically for growth and an aliquot was tested for cytolytic activity 
against  51Cr-labeled  MBL-2  target  ceils.  In  one  such  experiment,  55  out  of 96 
microcuhures were positive for growth  and  all  55  demonstrated cytolytic activity. 
Cells from six highly cytolytic microcuhures were selected for expansion and trans- 
ferred to  1-ml cultures that contained 5 ×  108 irradiated C57BL/6 spleen cells, 3 × 
105 irradiated MBL-2 cells, and 25% 2 °  MLC SN. Under these conditions, all six of 
these  putative  clonal  isolates grew  and  were subsequently  recloned  1 wk  later by 
limiting-dilution in micro-MLTC with 0.3 responding cells/well  (other attempts at 
expansion and recloning of micro-MLTC populations were similarly successful). All 
clones derived by this procedure were cytolytic for MBL-2 targets. These clones and 
others have been maintained in culture for >4 mo by passage of 5 ×  104 cells every 
3-5  d  in  1-ml  cultures  that  contained  irradiated  C57BL/6  syngeneic spleen  cells, 
irradiated MBL-2 tumor cells, and 2 ° MLC SN. 
To date, no clone has lost its high level of cytolytic activity or its cytolytic specificity. 
Fig.  1 compares the cytolytic activity of four of the derived clones. Although some 
degree of heterogeneity was seen, the levels of activity (50% lysis at effector:target cell 
ratios of0.3:1 to 3:1) were similar to or higher than those observed with mass cultures 
like those used to establish the clones (data not shown). 
Karyotypic analysis of four of the clones carried for 4 mo in culture revealed the 
normal  complement  of mouse  chromosomes,  and  no  aberrant  chromosomes were 
observed (M. Cianfriglia. Unpublished data.). 
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FIG.  1.  Cytolytic activity of MoLV-specific CTL clones. The cytolytic activity of four MoLV- 
specific C57BL/6 CTL clones was assessed against 5,000 ~lCr-labeled MBL-2 tumor cells in a 3.5-h 
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Kinetics  and Requirements for  Growth  of MoL V-specific  CTL  Clones.  To examine the 
growth requirements of MoLV-specific CTL clones, cultures  were prepared with  5 
×  104 cells from each of three clones using various supplements added  to standard 
culture medium. Cell recovery and cytolytic activity against MBL-2 target cells were 
assessed on days 2, 3, 4, and 6. Fig. 2 illustrates the pattern of growth of a clone (C5.2) 
in the presence of the indicated culture supplements, and Table I presents the cytolytic 
activity recovered from cultures of three clones on days 3 and 6. It is apparent from 
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FIG.  2.  Kinetics  and  requirements  for  growth  of  MoLV-specific  CTL  clones.  Cultures  were 
prepared with 5 ×  104 C5.2 cells in  1 ml of culture medium only (O), with 25%  2 °  MLC SN (11), 
with SN plus irradiated C57BL/6 spleen cells (El), with SN plus irradiated  MBL-2 (A), with SN 
plus irradiated spleen and irradiated MBL-2 cells (O), with irradiated spleen and irradiated MBL- 
2 cells (A). Viable cell recovery was assessed in replicate cultures on the days indicated. 
TABLE  I 
Requirements for the Generation of Cytolytic Activity in Cultures Prepared with MoL V-spec~c CTL 
Clones * 
Culture supplement 
Clone A.2.2  Clone 5.2  Clone F9.F8D 
Day 3  Day 6  Day 3  Day 6  Day 3  Day 6 
LU/culture (LU/ IO  6) 
None  <1  <1  <1  <1  <1  <1 
Irr. spleen +  MBL-2  3.3  1.5  6.7  5.7 (114)  14.3  7.4 (148) 
SN  3.1  3.7 (74)  4.0  11.9 (66)  21.3  100 (156) 
SN +  MBL-2  7.1  25.6 (128)  30.0  86.6 (94)  66.7  31.2 (26) 
SN +  irr. spleen  2.3  4.0 (67)  5.4  31.3 (238)  17.2  57.1  (101) 
SN ÷  MBL-2 +  irr. spleen  7.1  100  (182)  33.3  313  (332)  103  143  (108) 
* Cultures were prepared with 5 ×  104 cells from the indicated CTL clone in  1 ml of culture medium plus 
the indicated culture supplement, i.e.,  irradiated syngeneic MBL-2 lymphoma cells (MBL-2); irradiated 
syngeneic spleen cells (irr.  spleen), and 2 ° MLC SN (SN). After the indicated period of culture, cytolytic 
activity against nlCr-labeled MBL-2  target  cells was assessed. LU were calculated  from dose-response 
curves,  1 LU equals the  number of lymphocytes required  to  produce  50%  specific ~lCr  release.  The 
number of LU/108 lymphocytes or LU/culture was determined as described previously (t6). A.  WEISS,  K.  BRUNNER,  H.  MACDONALD,  AND J.-G.  CEROTTINI  1215 
these data that  there is an absolute requirement for 2 °  MLC SN, but optimal cell 
recovery and cytolytic activity were also dependent upon the presence of syngeneic 
irradiated spleen cells and stimulating antigen (MBL-2). In general, peak cell recovery 
(ranging from 5 ×  10  a to 3 ×  10n/culture) was observed by day 4 and appeared to 
depend to some extent on the length of a  lag period that all clones underwent after 
transfer. After the 6th d in culture, cell recovery and lytic activity diminished rapidly 
(data not shown). 
Frequency Analysis of CTL-P in MoL V-specific Clones.  Limiting-dilution analysis was 
used to determine the frequency of CTL-P in three clones. The frequency varied from 
33-100%, suggesting a homogeneous population of cells with a high plating efficiency 
(Fig. 3). 
Lyt Antigen  Phenotype of MoLV-specific  CTL  Clones.  Flow cytometric analysis  that 
employed monoclonal rat anti-Lyt-1 and anti-Lyt-2 antibodies was used to assess the 
Lyt phenotype of several of the  MoLV-specific CTL clones.  Fig.  4  compares  the 
fluorescence  profiles  of three  clones  with  those  obtained  with  normal  C57BL/6 
thymocytes. It can be seen that both Lyt-1 and Lyt-2 antigens were expressed on the 
surface of the cells of all three clones. It should be noted that the relative amplification 
used to detect fluorescence on thymocytes was twice that  used for the CTL clones. 
Thus, the Lyt- 1 density of the CTL clones is at least equivalent to that on thymocytes, 
and  Lyt-2 appears even more abundant.  There was,  however, heterogeneity in the 
density of Lyt antigens among the various clones, the quantity of Lyt-1 on clone B 11.1 
being twice that  seen on A2.2  or C5.2.  The stability of this difference in  antigen 
density with time was confirmed in determinations 2 mo apart. 
Specificity ofMoLV-specific  CTL clones.  Previous studies in the MoLV system had 
demonstrated that  CTL contained in mass  MLTC populations preferentially lysed 
syngeneic  MoLV-derived  targets.  However, significant  lysis  of allogeneic  MoLV- 
derived tumor ceils could also be observed at relatively high lymphocyte:target cell 
ratios (6). Studies in micro-MLTC under limiting-dilution conditions further showed 
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Fla.  3.  Minimal estimate of the frequency of CTL-P in MoLV-specific CTL clones. Micro-MLTC 
were prepared with limiting numbers of cells from each CTL clone and assessed for cytolytic activity 
against SlCr-labeled MBL-2 cells after 7 d. The percent negative cultures at each cell dose was used 
to calculate the frequency (f) of CTL-P by the method of maximum log likelihood as described in 
Materials and Methods. l  E4.2 (f -- 1/2.7); Q, A2.2 (f =  1/2.6); A, B11.1  (f =  1/0.7). 1216  CYTOLYTIC T  LYMPHOCYTE  CLONES 
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Fro. 4.  Analysis of Lyt phenotype  of MoLV-specific CTL  clones by  flow microfluorometry. 
Normal C57BL/6 thymoeytes or the indicated CTL clones were incubated with rat monoclonal 
antibodies specific for Lyt-I or Lyt-2 antigens followed by fluoreseeinated rabbit  anti-rat  IgG. 
Samples were run on an FACS II gated to exclude nonviable cells. Fluorescence histograms were 
arbitrarily normalized. The dotted curve in each panel represents cells stained with the fluorescein- 
ated conjugate only. a.u., arbitrary units. 
that, in the C57BL/6 system, a small proportion of clones were able to lyse syngeneic 
and  allogeneic MoLV-derived  target cells  (13).  These  results suggested some degree 
of heterogeneity  among  MoLV-specific  CTL.  To  further  characterize  such  cross- 
reactive  MoLV-specific C57BL/6  CTL,  micro-MLTC were prepared  with  limiting 
numbers  of responding  cells  (two  to  four  cells/culture)  from  7-d  mass  cultures  of 
C57BL/6 regressor spleen cells previously stimulated with MoLV-infected syngeneic 
spleen cells. After 7 d, such microcultures were split  and assayed against  four tumor 
target-cell types, i.e., MBL-2 (H-2b), the syngeneic stimulating MoLV-derived tumor; 
LSTRA, an allogeneic MoLV-derived tumor;  EL-4 (H-2b), a  syngeneic non-MoLV- 
derived lymphoma; and P-815 (H-2a), an allogeneic non-MoLV-derived tumor. The 
results of one such experiment are illustrated  in Fig. 5, where the percent specific 51Cr 
release of positive cultures against MBL-2 is compared with that obtained with each 
of the other three target cells. Of a  total of 168 cultures, 31 demonstrated significant 
cytolytic activity against  MBL-2. Whereas the vast majority of these putative clones A. WEISS, K. BRUNNER, H.  MacDONALD, AND 
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FiG. 5.  Specificity  analysis of individual micro-MLTC. A limiting number of cells (two/culture) 
from a mass culture prepared with C57BL/6 regressor spleen cells were cultured in micro-MLTC 
with stimulating MBL-2 cells as described in  Materials and  Methods. After 7 d, each of 168 
individual microcultures was split and assessed for cytolytic activity against 2,000 51Cr-labeled 
target cells, which included the stimulating MoLV-derived  syngeneic  tumor (MBL-2), an allogeneic 
MoLV-derived tumor (LSTRA), a syngeneic non-MoLV-derived tumor (EL-4), or an aUogeneic 
non-MoLV-derived tumor (P-815). Two microcuhures (circled) were selected for further specificity 
studies after subeloning (Fig. 6). 
demonstrated  a  high  degree  of specificity,  lysing  only  MBL-2  targets,  a  smaller 
number demonstrated varying degrees of cross-reactivity with the other target cells. 
The  remaining  cells  in  two  of these cultures  (circled),  one specific  (D11)  and  one 
cross-reactive  against  LSTRA  and  P-815  (F9),  were  subcloned  in  micro-MLTC, 
expanded, and maintained in  1-ml cultures as described earlier in this report. 
The specificity of these 2 expanded CTL clones (and  12 others selected in a similar 
manner)  was  assessed  using  the  4  tumor targets  employed  in  the  initial  screening 
procedure.  At  least three patterns of reactivity were observed, as illustrated  by the 
three representative clones shown in Fig. 6. Two of these (D11.F1S and F9.F8D)  are 
subclones from microcuhures described in Fig. 5. All three clones demonstrated high 
levels  of  cytolytic  activity  toward  the  syngeneic  MoLV-derived  tumor,  MBL-2. 
However, although  D11.F1S  had  no significant  cytolytic activity against  the other 
three targets tested (Fig. 6a), A2.2 lysed LSTRA, though to a lesser extent, but again 
had no significant activity against EL-4 or P-815 (Fig. 6 b). In contrast, F9.F8D lysed 
both P-815 and LSTRA in addition to the syngeneic MoLV-derived lymphoma (Fig. 
6c).  As shown  in  Table II, of  14  selected  clones,  6,  2,  and  4  clearly exhibited  the 
patterns  exemplified by clones  D11.F1S,  A2.2,  and  F9.F8D,  respectively. The like- 
lihood  that  the  F9.F8D  pattern  corresponds  to  clones  that  cross-react  with  H-2  d 
alloantigens was supported by the ability of DBA/2  (H-2d), but not C57BL/6 spleen 
cells, to effectively function as cold target inhibitors when Fg.FSD was assayed against 
MBL-2  or P-815,  and  by the  ability of F9.F8D  to  lyse DBA/2,  but  not  C57BL/6 
concanavalin A blast target cells (data not shown). 
Stability  of Cytolytic Activity  of MoLV-specific  CTL Subclones.  Three clones  (A5,  E6, 
and  C3)  selected  for  their  representative  specificity  patterns  were  subcloned  by 
stimulating  limiting numbers of cells from each clone in  a  series of micro-MLTC. 
From  each  parental  clone,  three  randomly  selected  subclones  were  expanded  and 
tested at different lymphocyte:target cell ratios for cytotoxicity against the four target 
cell types used for the initial selection. As shown in Fig. 7, all three subclones of each 
parental clone closely resembled each other in its specificity pattern. This demonstrates 
a  high  degree  of stability  of activity  and  specificity of the  subclones.  Occasional IJJ 
{/) 
QM 
.,.I 
I.w  n,, 
U 
uJ 
a. 
r~ 
I- 
Z 
~J 
0  h- 
a. 
100- 
50" 
100- 
50- 
100 
C 
50" 
0 
0.1 
~.D.  mm~m'O 
,.. ~  .,, ,~4)~  ~  ,~-A 
..,.-4 '~  o  .Lo° w  "~  .A 
,~,L..,m~,~..,:,.,al.  .... f.-"~-_'-..---'..... A ............... 
b 
j  .,s,.,  ~s  .,,," 
~, ,J* •  .  .........  & 
,*, •,,~.  ,0.....,&,,.0°°°~ ~,4~ 
-  i  i  i  !  i  i  ,  i  i  i  i  i  l", iii 
,,-" A ""°"""°°" 
/ 
/ 
/  s 
Z  ~,s 
°s 
s 
s 
s ° 
s  A 
°s" 
s,  S 
As" 
'  0:3  ......  1'  '  .'l  .....  "Ib  '  3b 
LYMPHOCYTE:  TARGET  CELL  RATIO 
Fie.  6.  Specificity patterns of CTL clones reactive with MoLV-associated cell surface antigens. 
Miero-MLTC were prepared as indicated in Fig. 5, and selected cultures were recloned by limiting- 
dilution and expanded. The cytolytic activity of clones D11.FIS (a), (25.2 (b), or F9.FSD (c) against 
the indicated 51Cr-laheled target was assessed in a  3.5-h S]Cr  release assay using 5,000 target cells/ 
well. O, MBL-2; O, EL-4; &, LSTRA; A, P-815. 
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LYMPHOCYTE:  TARGET  CELL  RATIO 
Fro.  7.  Stability of specificity and cytolytic activity of MoLV-specific CTL subclones. The cytolytic 
activity of each of three expanded subclones derived from three clones was assessed against 5,000 
S]Cr-labeled MBL-2 (O), EL-4 (O), LSTRA (A), or P-815 (/~) cells. 
retesting  of individual  subclones  up  to  4  mo  after  initial  isolation  confirmed  this 
stability (data not shown.). 
H-2D b Restriction of MoLV-specific  CTL Clones.  Previous reports (7)  suggested that 
CTL  of the  H-2  b  haplotype  demonstrate  H-2Db-restricted  recognition  of MoLV- 
antigens; however, this restriction has not been examined at the clonal level. Therefore, 
we investigated whether lysis of MBL-2 target cells by the CTL clones reported here 
could  be  inhibited  by alloantisera  or  monoclonal  antibodies  directed  against  H-2 
determinants. Using conventional alloantisera, it was found that anti-H-2  b serum was 
a  potent  inhibitor  of CTL  activity,  whereas  anti-H-2  d  serum  had  no  detectable 
inhibitory activity (data not shown). 
To  further  characterize  the  H-2  restriction  of  these  CTL  clones,  monoclonal 
antibodies  reactive  with  determinants  encoded  by  H-2D  b or  H-2K  b were  used  as 
inhibitors  in  the  CTL assay.  All  of the six  MoLV-specific CTL clones  tested were 
inhibited by both of the anti-H-2D  b monoclonal antibodies  (B22-249.R1  and H 141- 
30),  whereas  the  anti-K  b  monoclonal  antibody  (B8-24-1)  had  no  effect  (Fig.  8). 
Control  experiments established  that  the  anti-K  b monoclonal antibodies  effectively 
inhibited alloreactive B10A  (4R)  anti-C57BL/6  (i.e.,  anti-K~ CTL. 5 Thus, based on 
the  limited  number of MoLV-specific clones  examined,  these observations support 
previous mass culture results (7) of H-2Db-restricted lysis in the MoLV system. 
Discussion 
Previous studies had shown the feasibility to isolate CTL clones specific for MoLV- 
associated cell surface antigens by stimulation of regressor spleen cells in micro-MLTC 
s Weiss, A., H. R. MacDonald, J.-C. Cerottini, and K. T. Brunner. Inhibition of cytolytic T  lymphocyte 
clones  reactive  with  Moloney  leukemia  virus  associated  antigens  by  monoclonal  antibodies:  a  direct 
approach to the study of H-2 restriction.J.  Immunol, In press. A. WEISS, K. BRUNNER, H. MACDONALD, AND J.-C. CEROTTINI 
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Fzo. 8.  Inhibition of cytolytic activity of MoLV-specific CTL  clones by  monoclonai anti-H-2 
antibodies. SXCr-labeled MBL-2 (2,000/cuhure) were incubatod for 30 rain at 22°C in the presence 
of the indicated dilution of B22-249.R 1, anti H-2D  b (A); H141-30, anti H-2D  b (A); or B8-24-1, anti 
H-2K  b (0). The eytolytic activity of clones A2.2  (a), B I 1.1  (b), (]5.2 (c), Fg.FSD (d), FI0.1  (e), or 
E4.2 (f) was then assessed  at a  ratio of one lymphocyte:target cell in a  3.5-h assay.  Dotted lines 
correspond to cytolysis in the absence of inhibitor. 
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under limiting-dilution conditions (13). However, the study of the specificity of such 
clones had been hampered by the limited number of cells generated. Our study shows 
that CTL clones obtained under limiting-dilution conditions can be expanded readily 
and maintained in culture for extended periods of time under appropriate culture 
conditions, i.e., in the presence of antigen (stimulating tumor or infected spleen cells), 
accessory cells (irradiated syngeneic spleen cells), and a source of T  cell growth factor 
(TCGF)  (2 ° MLC SN). The application of this technique provided large numbers of 
homogeneous CTL for detailed analysis of Lyt phenotype, specificity, and phenotypic 
stability. 
Regressor spleen cells stimulated in mass culture with MoLV-infeeted spleen cells 
were used as a starting population to generate CTL clones. Limiting-dilution analysis 
indicated that the frequency of CTL-P in such populations had increased dramatically 
after in vitro stimulation, i.e., was between 15 and 50% (K. T. Brunner. Unpublished 
observations.). This allowed the use of very low responder cell numbers (2-3/micro- 1222  CYTOLYTIC T  LYMPHOCYTE CLONES 
culture), thus increasing the probability that CTL contained in individual microcul- 
tures  were  derived  from  single  precursor  cells  (i.e.,  were  monoclonal)  even  at  a 
relatively high percentage of positive cultures. Such putative clones were then selected, 
expanded, and recloned by limiting-dilution. Results comparing the cytolytic patterns 
of original  and  recloned populations  in  most  instances  suggested  clonality of the 
original isolates (Fig. 7). 
Our study as well as those of Glasebrook and Fitch (19,  20)  suggest an important 
role of antigen in the maintenance of specificity and  high cytolytic activity during 
expansion of CTL clones in TCGF-containing medium. As reported by Nabholz et al. 
(21), maintenance of cloned CTL lines in TCGF without additional antigen often led 
to  loss  of cytolytic  activity,  loss  of specificity,  and  appearance  of chromosomal 
aberrations. In contrast, such changes have not been observed with the MoLV-specific 
CTL clones reported here, at least within the 4-mo period during which they have 
been maintained in culture. Furthermore, the culture conditions used in our study 
appear to allow the isolation of large numbers of expanded CTL clones, insofar as 16 
of 20 attempts to expand selected clones have been successful. 
As  assessed  by flow microfluorometry using  monoclonal antibodies,  the  MoLV- 
specific CTL clones tested expressed both Lyt-1 and Lyt-2 antigens. These findings 
are in apparent disagreement with those of Leclerc and Cantor (8), who reported that 
the cytolytic activity of MoLV-specific CTL populations was unaffected by treatment 
with anti-Lyt-1 alloantiserum and complement. However, it is likely that this discrep- 
ancy can be explained by a relative resistance of CTL to lysis by anti-Lyt-1 antibody 
plus complement. Indeed, although early studies suggested that alloreactive CTL did 
not  express  Lyt-1  antigens,  recent  data  from  Nakayama et  al.  (22)  and  from  this 
laboratory  6 clearly indicate that such CTL are Lyt-l+2  +. Thus, it is evident that the 
MoLV-specific clones  reported here have  the  same  Lyt  phenotype as  alloreactive 
CTL. 
In previous studies, the specificity analysis of CTL clones derived from regressor 
spleens had  demonstrated cross-reactivity of a  small  percentage of the clones  (7%) 
with allogeneic tumor target cells (13). Our studies confirm and extend these findings. 
Using four (two additional) target cell types, clones with three patterns of specificity 
were observed. A large majority of the clones was restricted to the syngeneic tumor, 
and  a  small  (undetermined)  percentage either cross-reacted with a  MoLV-derived 
tumor or (apparently) with H-2  d alloantigens.  14 clones (Table II) were selected and 
analyzed for clonality and  phenotypic stability  after expansion  and  recloning.  As 
shown in a  representative experiment (Fig.  7), a  high degree of phenotypic stability 
was observed, with only minor differences in activity and specificity patterns between 
three  subclones  derived  from  each  of three  different  cloned  parent  populations. 
Several of these clones were retested over a  period of 4  mo, and all were found to 
maintain  their high cytolytic activity and  their specificity (A.  Weiss.  Unpublished 
results.). 
In the studies reported here, interesting clones were selected on the basis of their 
specificity  pattern.  Certainly,  these  clones  are  not  likely  to  represent  the  whole 
repertoire of MoLV antigen-reactive CTL-P in  the  C57BL/6  mouse,  nor has  any 
6  Cerottini, J.-C., and H. R. MacDonald. Limiting dilution analysis of alloantigen-reactive  T lympho- 
cytes. V. Lyt phenotype of cytolytic  T lymphocyte  precursors reactive against normal and mutant H-2 
antigens.,], lmmunol. In press. A. WEISS, K. BRUNNER, H.  MACDONALD, AND J.-C. CEROTTINI  1223 
attempt  been  made  to  determine  the  frequency  of clones  that  express  any  given 
phenotype. Studies  in which  individual  CTL clones are tested for cytolytic activity 
against syngeneic target cells infected with other viruses and against various allogeneic 
target cells are required  to further analyze the specificity repertoire of CTL in this 
system. 
The  restriction  of MoLV-specific CTL  for  target  cells  that  bear  syngeneic  H-2 
determinants has been well documented  (6,  7,  23,  24).  In particular, Gomard et al. 
(7) reported that in the H-2  b and H-2  d haplotypes, CTL recognition was restricted to 
the  H-2D  b and  H-2K  d regions,  respectively. The  studies  reported  here  (and  other 
studies) n that employed monoclonal anti-H-2K  b and anti-H-2D  b antibodies support 
and extend  to the clonal  level the conclusions of Gomard et al.  (7)  concerning the 
restriction of MoLV-specific CTL in the C57BL/6 mouse. All of 6 clones tested (and 
in  other  experiments  44  of  51  additional  ones) 5  were  inhibited  by  anti-H-2D  b 
monoclonal  antibodies,  whereas  none  were  inhibited  by  anti-H-2K  b  monoclonal 
antibodies. It remains to be determined whether the basis for such a  high degree of 
restriction to H-2D  b is related to the selective incorporation of H-2D  b molecules into 
the virion envelope (25).  In view of a  recent  report that  suggested that  intact virus 
could  substitute  for tumor cells  in  the  generation  of MoLV-specific CTL  in  mass 
culture (26), experiments are in progress to examine if viral preparations can be used 
as a source of antigen for the isolation and maintenance of CTL clones. 
Summary 
Cytolytic T  lymphocyte (CTL) clones specific for Moloney leukemia virus (MoLV)- 
derived tumor cells were generated by placing limiting numbers ofC57BL/6 responder 
cells  into  mixed  leukocyte-tumor cell  microcultures.  Under  appropriate conditions 
(presence of stimulating tumor cells, accessory cells, and T  cell growth factor), such 
cloned CTL could readily be expanded  to provide large numbers of homogeneous, 
highly cytolytic CTL populations for further characterization.  Using four target-cell 
types, three specificity patterns were observed: one reactive with the syngeneic MoLV- 
derived tumor only, one cross-reactive with an allogeneic MoLV-derived tumor, and 
one cross-reactive with  normal  allogeneic cells.  Subclones  derived  from these  three 
types  of clones  exhibited  a  high  degree  of stability  in  terms  of lytic  activity  and 
specificity over a 4-mo period of observation. Three clones analyzed by flow cytoflu- 
orometry using monoclonal antibodies were all found to be of the Lyt-1 +2 + phenotype. 
Furthermore, lysis of target cells by all of six clones tested was inhibited  by anti-H- 
2D  b (but not by anti-H-2K  b) monoclonal antibodies, demonstrating H-2Db-restriction 
at the clonal level. 
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infection of neonatal mice, Doctors G. HSmmerling and G. Kohler for providing the monoclonal 
antibodies, Doctors H. Engers and M. Nabholz for stimulating discussions, P. Corth~sy and C. 
Horvath for their excellent technical assistance, C. Taswell for providing the computer program 
used for the statistical  evaluation of the data, and Mine Cesco for typing the manuscript. 
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